Outset Medical
101 hedge funds and large institutions have $253M invested in Outset Medical in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 11 closing their positions.
73% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 11
7% more funds holding
Funds holding: 94 → 101 (+7)
0% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 33
5.19% less ownership
Funds ownership: 105.55% → 100.36% (-5.2%)
28% less capital invested
Capital invested by funds: $352M → $253M (-$99.8M)
32% less call options, than puts
Call options by funds: $40K | Put options by funds: $59K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.88M |
| 2 |
Morgan Stanley
New York
|
+$4.86M |
| 3 |
BlackRock
New York
|
+$4.13M |
| 4 |
Millennium Management
New York
|
+$4.1M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$25.3M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$9.88M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$6.61M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.21M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.76M |
OM Hedge Fund Activity: Q3 2025 in Review
101 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2025, worth a combined $253M — down 28% from $352M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new OM positions and 11 closed out — a net gain of 8 holders — while 33 added to existing stakes and 33 trimmed.
The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $5.88M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $25.3M.
- 101 institutional investors held Outset Medical (OM) as of Q3 2025, up from 94 in Q2 2025.
- Funds reported $253M of Outset Medical stock for Q3 2025, down 28% quarter-over-quarter.
- 19 funds opened new Outset Medical positions in Q3 2025 and 11 closed out, a net change of +8 holders.
- The largest Outset Medical buyer in Q3 2025 was Assenagon Asset Management, an estimated $5.88M added.
- The largest Outset Medical seller in Q3 2025 was T. Rowe Price Investment Management, an estimated $25.3M sold.
Based on aggregated 13F filings for Q3 2025.